BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Large Growth in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant increase in short interest in the month of April. As of April 30th, there was short interest totaling 8,700 shares, an increase of 690.9% from the April 15th total of 1,100 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 7,445 shares, the days-to-cover ratio is currently 1.2 days.

BioNxt Solutions Stock Performance

BNXTF stock opened at $0.32 on Tuesday. The firm has a market cap of $39.26 million, a PE ratio of -8.01 and a beta of 0.69. The firm’s fifty day moving average is $0.39 and its 200 day moving average is $0.44. BioNxt Solutions has a one year low of $0.26 and a one year high of $0.80.

BioNxt Solutions (OTCMKTS:BNXTF) last released its quarterly earnings results on Wednesday, April 29th. The company reported ($0.01) EPS for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.